104
Participants
Start Date
September 1, 2016
Primary Completion Date
February 16, 2018
Study Completion Date
May 31, 2018
Selonsertib
18 mg tablet administered orally once daily
Prednisolone
40 mg (4 x 10 mg tablets) administered orally once daily
Placebo
Selonsertib placebo tablet administered orally once daily
Cedars Sinai Medical Center, Los Angeles
University of Arkansas for Medical Sciences, Little Rock
Southern California Research Centers, Coronado
Cleveland Clinic Florida, Weston
Oschner Medical Center, New Orleans
Beth Israel Deaconess Medical Center, Boston
University of Michigan, Ann Arbor
University of Pennsylvania, Philadelphia
Methodist Healthcare Dallas - The Liver Institute, Dallas
Liver Institute of Virginia, Newport News
University of Washington, Seattle
Medizinische Universitat Graz, Graz
Universitätsklinik für Innere Medizin I, Innsbruck
Medical University Vienna, Vienna
Cliniques Universitaires UCL Saint-Luc, Brussels
CUB Hopital Erasme, Brussels
Ghent University Hospital, Ghent
Universitair Ziekenhuis Leuven, Leuven
Centre Hospitalier Universitaire de Liege, Liège
University of Calgary, Calgary
University of Manitoba, Winnipeg
Toronto General Hospital, Toronto
CHU Amiens Picardie, Amiens
CHU Angers, Angers
Hôpital Jean Minjoz, Besançon
C.H.U. de Caen, Caen
CHU henri Mondor, Créteil
CHU de Grenoble- Hopital Michallon, La Tronche
CHRU de Lille, Lille
Hôpital de la Croix Rousse, Lyon
Hopital La Pitie Salpetriere, Paris
Hopital Paul Brousse, Villejuif
University of Zurich, Zurich
Brighton & Sussex University Hospitals NHS Trust, Brighton
Hull and East Yorkshire Hospitals NHS Trust, Hull
Royal Liverpool & Broadgreen University Hospitals NHS Trust, Liverpool
Barts Health NHS Trust, London
Chelsea and Westminster Hospital, London
Imperial College, London
Kings College Hospital NHS Trust, London
Freeman Hospital, Newcastle
Nottingham University Hospitals NHS Trust, Nottingham
Derriford Hospital, Plymouth
Portsmouth Hospitals NHS Trust, Portsmouth
Lead Sponsor
Gilead Sciences
INDUSTRY